Cervix Cancer Research Network (CCRN): Improving Access to Cervix Cancer Trials on a Global Scale

Gaffney D 1 , Small B , Kitchener H , Young Ryu S , Viswanathan A , Trimble T Show all authors , Covens A , Wilailak S , Lertkhachonsuk AA , Sitathanee C , Mahantshetty U , Fisher B , Springer S , Pollatz T , Spiller A , Bacon M , Jhingran A

Affiliations 

  • 1 *Department of Radiation Oncology, University of Utah, Salt Lake City, UT; †Department of Surgery, Loyola University, Chicago, IL; ‡Institute of Cancer Sciences, University of Manchester, Manchester, UK; §Department of Obstetrics and Gynecology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea; ∥Department of Radiation Oncology, John Hopkins University, Baltimore, MD; ¶National Cancer Institute, Washington, DC; #Sunnybrook Health Science Center, Toronto, Canada; **Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; ††Tata Memorial Hospital, Mumbai, India; ‡‡Radiating Hope, Salt Lake City, UT; §§Elekta, Veenendaal, the Netherlands; ∥∥Varian Medical Systems, Palo Alto, CA; ¶¶BEBIG, Lübeck Area, Germany; ##Gynecologic Cancer InterGroup, Kingston, Ontario, Canada; and ***The University of Texas MD Anderson Cancer Center, Houston, TX
Int. J. Gynecol. Cancer, 2016 11;26(9):1690-1693.
PMID: 27779548

Abstract

Eighty-seven percent of cervix cancer occurs in less-developed regions of the world, and there is up to an 18-fold difference in mortality rate for cervix cancer depending on the region of the world. The Cervix Cancer Research Network (CCRN) was founded through the Gynecologic Cancer InterGroup with the aim of improving access to clinical trials in cervix cancer worldwide, and in so doing improving standards of care. The CCRN recently held its first international educational symposium in Bangkok. Sixty-two participants attended from 16 different countries including Pakistan, India, Bangladesh, Thailand, Malaysia, Singapore, Philippines, Taiwan, China, Vietnam, Korea, Japan, Columbia, Brazil, Canada, and the United States. The focus of this symposium was to evaluate progress, to promote new clinical trials for the CCRN, and to provide education regarding the role of brachytherapy in the treatment of cervical cancer.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications